International Cancer Imaging Society

Our Journal - Cancer Imaging

Our Journal 1
Our Journal 1


Cancer Imaging is the official journal of ICIS, an open access, peer-reviewed journal published by BioMed Central. Original articles, as well as reviews and editorials written by international imaging experts with a subspecialty focus on oncology, are published regularly online;  sign up for alerts to keep up-to-date with the latest articles. Cancer Imaging Impact factor for 2014 is 2.07 with a  5 year impact factor of 2.46.

The journal encompasses CT, MRI, ultrasound, single photon and positron emission tomography, including multimodality imaging in all kinds of malignant tumours, plus new developments, techniques and innovations.

All articles published in Cancer Imaging are included in PubMed, the most widely used biomedical bibliographic database service, as well as Embase, EmCare, Google Scholar, MEDLINE, Science Citation Index and Scopus. The full text of all research articles is deposited in PubMed Central, the US National Library of Medicine's full-text repository of life science literature.

ICIS Members receive 15% discount on article-processing fees.

Submit your next manuscript to Cancer Imaging and take full advantage of the following:

Our Journal 5

Members Area

Subscribe to our mailing list

* indicates required
Email Format

Cancer / Oncology News From Medical News Today

The silence of the genes

Published: Wed, 25 Nov 2015 17:00:00 GMT

New insights into genomic imprinting.Research led by Dr. Keiji Tanimoto from the University of Tsukuba, Japan, has brought us closer to understanding the mechanisms underlying the phenomenon of...

New study on complete response rates for late-stage cancer

Published: Wed, 25 Nov 2015 16:00:00 GMT

The researchers reported the results of a meta-analysis of 68 chemotherapy trials for cancer treatment between 2000 and 2006 - before the gradual introduction of targeted cancer therapies (drugs that...

Optimal care for older cancer patients should target relevant HRQOL domains according to EORTC study

Published: Wed, 25 Nov 2015 16:00:00 GMT

In a paper recently published in the European Journal of Cancer, EORTC researchers identified health related quality of life (HRQOL) components that should be considered as most relevant for...

European Commission approves Blincyto for acute lymphoblastic leukemia

Published: Wed, 25 Nov 2015 15:00:00 GMT

Amgen has announced that the European Commission (EC) has granted conditional marketing authorization for BLINCYTO® (blinatumomab) for the treatment of adults with Philadelphia...

Combination therapy can prevent cytostatic resistance

Published: Wed, 25 Nov 2015 12:00:00 GMT

Researchers at Karolinska Institutet in Sweden have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of...

Virginia Tech's Verbridge and Davalos describe novel tumor treatment in Scientific Reports

Published: Wed, 25 Nov 2015 10:00:00 GMT

In the first published results from a $386,000 National Cancer Institute grant awarded earlier this year, a paper by Scott Verbridge and Rafael Davalos in Scientific Reports has been published.

Investigational drug may prevent life-threatening muscle loss in advanced cancers

Published: Tue, 24 Nov 2015 18:00:00 GMT

Preclinical study of oral drug stops inflammatory processes that result in severe cachexia.

Fat cells originating from bone marrow found in humans

Published: Tue, 24 Nov 2015 18:00:00 GMT

Cells could contribute to diabetes, heart disease.Researchers at the University of Colorado Anschutz Medical Campus have found that fat cells produced by stem cells from the bone marrow may be...

Pioneering 'Science to Survive' pipeline gives cancer patients hope for a brighter future

Published: Tue, 24 Nov 2015 17:00:00 GMT

Potentially life-saving therapies for cancer will be accelerated into clinical trials more quickly due to a pioneering project launched by scientists and clinicians at the University of Sheffield.

An ounce of cancer prevention is worth a moment of your attention

Published: Tue, 24 Nov 2015 17:00:00 GMT

What if you could visit the doctor for a blood test that predicted your personal cancer risk - then got a simple prescription that reduced that risk?


Nuada Medical


12 November 2015

Congratulations to our 2015 prize winners!

Congratulations to our 2015 prize winners!

The First Prize for the Oral Presentation has been awarded to Dr. Stephen Raskin for his presentation on ‘Target versus Non-target Lesions in Determining Disease Progression: ...
» Read more » Other news items